Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    bluebird bio Inc.

    NASDAQ: BLUE · Real-Time Price · USD
    4.97
    0.00 (0.00%)
    At close: May 30, 2025, 3:59 PM
    4.99
    0.40%
    After-hours: May 30, 2025, 07:05 PM EDT

    bluebird bio Statistics

    Share Statistics

    bluebird bio has 9.79M shares outstanding. The number of shares has increased by 1% in one year.

    Shares Outstanding

    n/a
    		 9.79M

    Shares Change (YoY)

    n/a
    		 1%

    Shares Change (QoQ)

    n/a
    		 0.53%

    Owned by Institutions (%)

    n/a
    		 1.46%

    Shares Floating

    n/a
    		 9.73M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,379

    FTD / Avg. Volume

    n/a
    		 0.24%

    Short Selling Information

    The latest short interest is 499.55K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 499.55K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.34 and the forward PE ratio is -0.58. bluebird bio's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.34

    Forward PE

    n/a
    		 -0.58

    PS Ratio

    n/a
    		 0.96

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -2.56

    P/FCF Ratio

    n/a
    		 -0.31

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for bluebird bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.48, with a Debt / Equity ratio of -11.36.

    Current Ratio

    n/a
    		 0.48

    Quick Ratio

    n/a
    		 0.28

    Debt / Equity

    n/a
    		 -11.36

    Debt / EBITDA

    n/a
    		 -2.28

    Debt / FCF

    n/a
    		 -1.36

    Interest Coverage

    n/a
    		 -11.98

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $337,931.45

    Profits Per Employee

    n/a
    		 $-970,625

    Employee Count

    n/a
    		 248

    Asset Turnover

    n/a
    		 0.18

    Inventory Turnover

    n/a
    		 1.37

    Taxes

    Income Tax

    n/a
    		 70K

    Effective Tax Rate

    n/a
    		 -0.03%

    Stock Price Statistics

    The stock price has increased by -72.83% in the last 52 weeks. The beta is 0.36, so bluebird bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.36

    52-Week Price Change

    n/a
    		 -72.83%

    50-Day Moving Average

    n/a
    		 4.42

    200-Day Moving Average

    n/a
    		 7.51

    Relative Strength Index (RSI)

    n/a
    		 62.84

    Average Volume (20 Days)

    n/a
    		 576,322

    Income Statement

    In the last 12 months, bluebird bio had revenue of 83.81M and earned -240.72M in profits. Earnings per share was -24.84.

    Revenue

    n/a
    		 83.81M

    Gross Profit

    n/a
    		 -5.57M

    Operating Income

    n/a
    		 -270.46M

    Net Income

    n/a
    		 -240.72M

    EBITDA

    n/a
    		 -156.82M

    EBIT

    n/a
    		 -218.07M

    Earnings Per Share (EPS)

    n/a
    		 -24.84
    Full Income Statement

    Balance Sheet

    The company has 62.3M in cash and 358.24M in debt, giving a net cash position of -295.93M.

    Cash & Cash Equivalents

    n/a
    		 62.3M

    Total Debt

    n/a
    		 358.24M

    Net Cash

    n/a
    		 -295.93M

    Retained Earnings

    n/a
    		 -4.5B

    Total Assets

    n/a
    		 295.96M

    Working Capital

    n/a
    		 -140.55M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -260.02M and capital expenditures -2.6M, giving a free cash flow of -262.62M.

    Operating Cash Flow

    n/a
    		 -260.02M

    Capital Expenditures

    n/a
    		 -2.6M

    Free Cash Flow

    n/a
    		 -262.62M

    FCF Per Share

    n/a
    		 -27.1
    Full Cash Flow Statement

    Margins

    Gross margin is -6.65%, with operating and profit margins of -322.72% and -287.23%.

    Gross Margin

    n/a
    		 -6.65%

    Operating Margin

    n/a
    		 -322.72%

    Pretax Margin

    n/a
    		 -287.14%

    Profit Margin

    n/a
    		 -287.23%

    EBITDA Margin

    n/a
    		 -187.12%

    EBIT Margin

    n/a
    		 -322.72%

    FCF Margin

    n/a
    		 -313.36%

    Dividends & Yields

    BLUE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BLUE is $10, which is 101.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 101.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 13, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Dec 13, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -23.56

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist